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ABSTRACT  
Renal cell carcinoma (RCC) with angioleiomyoma-like stroma appears to be molecularly 
distinct from clear cell RCC; however, its relationship to clear cell papillary RCC remains 
debated. Recent studies have found that similar tumors sometimes occur in patients with 
tuberous sclerosis complex (TSC), of which one study found unexpectedly negative 
succinate dehydrogenase (SDH) B immunostaining. We evaluated immunohistochemistry 
for SDHB in 12 apparently sporadic RCCs with angioleiomyoma-like stroma and 
correlated with clinical information for stigmata of TSC. Tumors were compared to a 
group of 16 clear cell papillary RCCs and 6 unclassified tumors with prominent stroma. 
With exception of 1 unclassified tumor, all exhibited at least focal cytoplasmic staining for 
SDHB protein, often requiring high magnification and better appreciated with increased 
antibody concentration. Detailed history information was available for 9/12 patients with 
smooth muscle-rich tumors, revealing no stigmata of undiagnosed TSC. Electron 
microscopy performed on 1 of these tumors revealed mitochondria to be very sparse, 
potentially accounting for the weak immunohistochemical labeling for SDHB protein. 
Weak SDHB immunostaining may represent another shared feature of RCC with 
angioleiomyoma-like stroma and clear cell papillary RCC, likely due to sparse 
mitochondria, strengthening the possible relationship of these entities. Although smooth 
muscle-rich tumors have been recently reported in patients with TSC, absence of staining 
in tumors with this pattern may not be specific for TSC. In tumors with pale or clear 
cytoplasm, immunohistochemical staining for SDHB should be interpreted with caution as 
evidence of abnormality in the SDH pathway. 
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 Introduction 
 Renal cell carcinomas with angioleiomyoma-like stroma(1, 2) and likely related 
entities renal cell carcinoma with smooth muscle stroma(3, 4) and renal 
angiomyoadenomatous tumor,(5, 6) are thought to be immunohistochemically and 
molecularly distinct from clear cell renal cell carcinoma.(2, 7) However, it remains debated 
whether these tumors should be regarded as variants of clear cell papillary renal cell 
carcinoma,(8-10) due to the shared features of cytokeratin 7 and high molecular weight 
keratin immunohistochemical labeling and lack of reactivity for alpha-methyl-acyl-coA-
racemase (AMACR), combined with absence of other defining genetic alterations.(2, 7)  
 
Interestingly, two recent reports have noted a tendency to encounter a similar 
morphology in patients with tuberous sclerosis complex,(11, 12) of which one study found 
the tumors to be unexpectedly negative for succinate dehydrogenase B (SDHB) 
immunohistochemical staining.(12) We therefore sought to assess SDHB 
immunohistochemical staining in a cohort of apparently sporadic tumors with smooth 
muscle stroma, to determine whether negative staining is consistently associated with this 
morphology, or with tuberous sclerosis-associated tumors. 
 
Materials and Methods 
 A cohort of 12 renal cell carcinomas with angioleiomyoma-like stroma from 11 
patients were selected for analysis, of which 10 tumors from 9 patients were previously 
reported(2) and 2 represent additional unpublished cases. These were compared to 16 clear 
cell papillary renal cell carcinoma tumors and 6 unclassified tumors with prominent 
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stroma, not fitting cleanly into a distinct category. The unclassified group included 1 tumor 
that upon review was interpreted as likely sarcomatoid renal cell carcinoma with the 
spindle-shaped cell component mimicking myoid stroma, 2 which had suggestive 
morphology and immunohistochemical phenotype but were shown to have chromosome 3p 
deletion using fluorescence in situ hybridization (FISH), 1 that had similar morphology 
and immunohistochemical staining pattern but was predominantly papillary (even more 
strongly resembling the tuberous sclerosis-associated morphology), and 1 that had 
borderline features between renal cell carcinoma with angioleiomyoma-like stroma and 
clear cell papillary renal cell carcinoma, all of which had been in the excluded group from 
a prior series.(2) 
Immunohistochemistry for SDHB was performed on 4-micrometer thick formalin-
fixed paraffin-embedded tissue sections following pressure cooker antigen retrieval (Target 
Retrieval Solution, pH 6.1; Dako, Carpinteria, CA) using a mouse monoclonal antibody 
directed against SDHB (at both 1:100 and 1:50 dilutions; 40 min incubation; clone 
21A11AE7, Abcam, Cambridge, MA). Control cases of known SDH-deficient tumors 
were also tested at the increased concentration to confirm that their abnormal negative 
staining was retained under these conditions. Detailed clinical, imaging, and family history 
was available for 9/11 of the patients with renal cell carcinoma with angioleiomyoma-like 
stroma to evaluate for stigmata of undiagnosed tuberous sclerosis. For electron 
microscopy, formalin-fixed but unprocessed tissue was retrieved from the remaining gross 
specimen after initial histologic examination in 1 renal cell carcinoma with 
angioleiomyoma-like stroma. This was subsequently fixed in glutaraldehyde, and 
processed according to routine protocol for clinical transmission electron microscopy in 
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the Henry Ford Health System electron microscopy laboratory. This study was approved 
by the Institutional Review Board of the Henry Ford Health System. 
 
Results 
 In renal cell carcinoma with angioleiomyoma-like stroma (Figure 1) and clear cell 
papillary renal cell carcinoma, SDHB immunohistochemical staining appeared near-
negative when performed at usual antibody concentration (1:100). Examination at high 
magnification and repeated analysis with increased antibody concentration (1:50) revealed 
at least focal fine cytoplasmic granular staining in all tumors. Detailed clinical, imaging, 
and family history information was available for 9 of 11 patients with renal cell carcinoma 
with angioleiomyoma-like stroma and revealed no angiomyolipomas or other findings to 
indicate undiagnosed tuberous sclerosis, although family histories revealed renal cysts and 
renal cancer in 2 patients and end-stage renal disease in 1. Immunohistochemistry 
remained equivocal (no definite positivity) in only 1 unclassified tumor (cytokeratin 7 
positive with clear cell morphology, but chromosome 3p deletion by FISH), even at the 
higher antibody concentration. Follow-up imaging in this patient revealed a solitary renal 
angiomyolipoma but no other lesions to suggest tuberous sclerosis, including no lesions 
identified by MRI of the brain. One unclassified tumor that even more strongly resembled 
the predominant papillary architecture of the tuberous sclerosis-associated tumors(11, 12) 
(Figure 2) also exhibited focal granular staining under high magnification and at higher 
antibody concentration. Electron microscopy was performed on 1 renal cell carcinoma with 
angioleiomyoma-like stroma revealed mitochondria to be very sparse (Figure 3). 
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Discussion 
 A rare and unusual group of renal cell tumors appears to share common features of 
nests and glands composed of cells with clear cytoplasm, combined with fibromuscular 
stroma and immunohistochemical reactivity for cytokeratin 7. Many of these have been 
found thus far to lack the typical genetic characteristics of clear cell renal cell 
carcinoma,(1-7, 13-17) although there are likely examples of clear cell renal cell carcinoma 
with chromosome 3p loss or VHL alterations that mimic this morphology for various 
reasons.(2, 7) The category of such renal cell tumors with prominent stroma has been 
referred to by several names, including renal cell carcinoma with angioleiomyoma-like 
stroma, renal cell carcinoma with smooth muscle stroma, renal angiomyoadenomatous 
tumor, among others,(1-7, 13-17) and to date it remains incompletely understood whether 
all of these represent a single entity, and whether any or all should be considered a variant 
of clear cell papillary renal cell carcinoma. 
The most recent International Society of Urological Pathology Vancouver 
Classification of Renal Neoplasia(18) and World Health Organization Classification(19) 
both largely place such tumors in the category of “provisional” or “emerging” entities, 
noting that some may be variants of clear cell papillary renal cell carcinoma, particularly 
those previously reported as renal angiomyoadenomatous tumor.(20) Although these 
usually share with clear cell papillary renal cell carcinoma the findings of 
immunohistochemical reactivity for cytokeratin 7, high molecular weight keratin, and 
carbonic anhydrase IX, with minimal or negative labeling for AMACR, they differ slightly 
in variably higher nuclear grade, positivity for CD10, and more robust myoid 
differentiation of the stroma.(2) They also appear to be much rarer than clear cell papillary 
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renal cell carcinoma, which is now recognized to be likely the 4
th
 most common renal cell 
carcinoma subtype.(21-23)  
The recent recognition of a similar morphology in patients with tuberous 
sclerosis(11, 12) raises the question of whether encountering this tumor morphology is a 
harbinger of undiagnosed tuberous sclerosis, whether these tumors are associated with 
tuberous sclerosis gene alterations in both the hereditary and sporadic settings (similar to 
VHL in clear cell renal cell carcinoma), or whether this morphology is enriched in tuberous 
sclerosis patients for other reasons. We reviewed medical histories from our cohort of 
patients, finding no conclusive evidence of tuberous sclerosis in this study; however, a 
recent abstract noted the opposite, with several patients meeting diagnostic criteria for 
tuberous sclerosis.(24) As such, our current working hypothesis is that this tumor 
morphology may occur both with tuberous sclerosis and sporadically, similar to what has 
been recently reported for the novel entity eosinophilic solid and cystic renal cell 
carcinoma,(25, 26) although further study is needed. 
One of the two studies of renal cancers in tuberous sclerosis patients found that the 
papillary renal cell carcinomas with fibromuscular stroma were abnormally negative for 
SDHB immunohistochemical staining,(12) an unexpected finding, since SDHB loss is 
intuitive in the setting of germline SDH subunit gene alterations(27-29) but not in the 
setting of TSC1 and TSC2 gene mutations. Therefore, we sought to assess whether this 
abnormal lack of SDHB staining in renal cell tumors is specific for the angioleiomyoma-
like stroma morphology, associated with tuberous sclerosis patients specifically, or occurs 
for other reasons. We found that although staining is typically very weak, at least focal 
cytoplasmic granular labeling can be appreciated in almost all of these tumors, especially 
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when staining is performed at higher antibody concentration and when viewed a high 
magnification. Electron microscopy in 1 tumor demonstrated very sparse mitochondria, 
which suggests that decreased mitochondrial density may be responsible for this near-
negative or false negative staining pattern. 
Of note, another recent abstract found decreased mitochondrial density in clear cell 
papillary renal cell carcinoma, in contrast to clear cell renal cell carcinoma and recently 
described entity TCEB1 mutant renal cell carcinoma,(30) adding additional support to this 
hypothesis. Our data showing similar weak staining in both entities (clear cell papillary 
renal cell carcinoma and tumors with angioleiomyoma-like stroma), combined with the 
results of Sarungbam et al(30) represent yet another potential link between these entities, 
perhaps supporting the concept that these represent a spectrum of the same disease, despite 
their differences. Of note, however, no convincing evidence of metastatic behavior has yet 
been reported from the comparatively large number of clear cell papillary renal cell 
carcinomas reported to date, casting doubt on whether these tumors should be considered 
malignant,(31) whereas the study by Verkarre et al found lymph node involvement 
associated with the considerably rarer renal tumors with angioleiomyoma-like stroma.(24)  
In summary, renal cell carcinoma with angioleiomyoma-like (or smooth muscle) 
stroma is a rare renal neoplasm with an incompletely understood relationship to tuberous 
sclerosis. Although it has been recently found in tuberous sclerosis patients that similar 
tumors have abnormal negative immunohistochemical staining for SDHB, we found that in 
the apparently sporadic counterparts, at least focal granular normal staining is appreciable, 
underscoring that interpretation should be approached with caution in tumors with clear 
cytoplasm,(32) especially clear cell papillary renal cell carcinoma and renal cell carcinoma 
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with angioleiomyoma-like stroma, which may share the finding of very low mitochondrial 
density.(30) Further study is needed to determine whether this tumor morphology has any 
implications for diagnosis of tuberous sclerosis.  
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Figure Legends 
 
Figure 1: (A, 100× magnification, hematoxylin and eosin) Renal cell carcinoma with 
angioleiomyoma-like stroma is composed of glandular structures dispersed in 
fibromuscular stroma, lined by cells with clear cytoplasm. (B, 200× magnification, 
hematoxylin and eosin) Higher magnification reveals nests and glandular structures with 
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clear to eosinophilic cytoplasm in abundant muscular stroma. (C, 600× magnification, anti-
SDHB immunohistochemical staining) Immunohistochemistry for SDHB performed at 
usual antibody concentration (1:100 dilution) appeared near-negative, although faint, focal 
cytoplasmic staining was observed (D, 600× magnification, anti-SDHB 
immunohistochemical staining) Repeated analysis with increased antibody concentration 
(1:50) revealed sparse but recognizable cytoplasmic granules. 
 
Figure 2: (A, 100× magnification, hematoxylin and eosin) This unclassified renal cell 
carcinoma demonstrated the papillary configuration with prominent muscular papillary 
cores that has been recently described as one subtype of renal tumor in patients with 
tuberous sclerosis. (B, 400× magnification, hematoxylin and eosin) Higher magnification 
reveals the papillary structures to be lined by cells with clear to flocculent or eosinophilic 
cytoplasm and readily identifiable nucleoli. (C, 600× magnification, anti-SDHB 
immunohistochemical staining) Immunohistochemistry for SDHB appeared near-negative, 
with minimal trace cytoplasmic labeling, prompting re-evaluation with higher antibody 
concentration. (D, 600× magnification, anti-SDHB immunohistochemical staining) At 
antibody dilution of 1:50, cytoplasmic granules were readily appreciable in the same 
tumor. 
 
Figure 3: (A) Electron microscopy was performed in one renal cell carcinoma with 
angioleiomyoma-like stroma tumor, and revealed the neoplastic glands to be lined by cells 
with voluminous granular cytoplasm and small, abortive brush border elements (direct 
magnification 2200×, scale bar 4 µm). (B) Mitochondria were sparsely distributed within 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Williamson et al – Smooth muscle renal cell carcinoma 
 17 
the epithelial cells’ cytoplasm (direct magnification 5600×, scale bar 2 µm), potentially 
explaining the scant immunohistochemical labeling for SDHB protein (a mitochondrial 
protein). 
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 SDHB staining is weak but focally present in renal tumors with smooth muscle stroma 
 Clear cell papillary renal cell carcinoma exhibits a similar staining pattern 
 These findings are likely the result of sparse mitochondria rather than protein defect 
 Further study is needed to determine if this is tumor is related to tuberous sclerosis 
